Artis Q.zen biplane
Device AT - Fixed interventional x-ray/angiography fluoroscopy
PDI 04056869010038
General payments
$2,079
Research payments
$77,000
Through program year 2025, $2,079 in general payments and $77,000 in research payments were reported against Artis Q.zen biplane (AT - Fixed interventional x-ray/angiography fluoroscopy).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $147 | 1 |
| 2025 | Research | $20,000 | 1 |
| 2024 | General | $1,206 | 24 |
| 2024 | Research | $30,000 | 1 |
| 2023 | General | $538 | 8 |
| 2022 | General | $44 | 3 |
| 2022 | Research | $6,750 | 1 |
| 2021 | General | $144 | 5 |
| 2021 | Research | $20,250 | 1 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
41 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.